Body Mass Index Changes and Chronic Neuroleptic Drug Treatment for Tourette Syndrome

Pediatric Neurology

Volumn 41, Issue 3, 2009, Pages 183-186

  Degrauw, Roosje S ^a   Li, Jason Z ^a   Gilbert, Donald L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; GUANFACINE; PIMOZIDE; RISPERIDONE; VALPROIC ACID;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ADOLESCENT DEVELOPMENT; AGE FACTORS; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BODY COMPOSITION; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; MALE; PIMOZIDE; REGRESSION ANALYSIS; RISPERIDONE; TIME FACTORS; TOURETTE SYNDROME;

EID: 67949099158     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2009.04.002     Document Type: Article

References (10)

1. Leckman J.F., Zhang H., Vitale A., et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 102 (1998) 14-19
2. Kurlan R., Como P.G., Miller B., et al. The behavioral spectrum of tic disorders: a community-based study. Neurology 59 (2002) 414-420
3. Singer H.S. Tourette's syndrome: from behaviour to biology. Lancet Neurol 4 (2005) 149-159
4. Gilbert D. Treatment of children and adolescents with tics and Tourette syndrome. J Child Neurol 21 (2006) 690-700
5. Scahill L., Leckman J.F., Schultz R.T., Katsovich L., and Peterson B.S. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60 (2003) 1130-1135
6. Gilbert D.L., Batterson J.R., Sethuraman G., and Sallee F.R. Tic reduction with risperidone vs. pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 43 (2004) 206-214
7. Scahill L., Erenberg G., Berlin Jr. C.M., et al. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 3 (2006) 192-206
8. Gilbert D.L., and Buncher C.R. Assessment of scientific and ethical issues in two randomized clinical trial designs for patients with Tourette's syndrome: a model for studies of multiple neuropsychiatric diagnoses. J Neuropsychiatry Clin Neurosci 17 (2005) 324-332
9. Ondo W.G., Jong D., and Davis A. Comparison of weight gain in treatments for Tourette syndrome: tetrabenazine versus neuroleptic drugs. J Child Neurol 23 (2008) 435-437
10. Gunturu S.D., and Ten S. Complications of obesity in childhood. Pediatr Ann 36 (2007) 96-101